Suppr超能文献

新冠疫情前后住院精神分裂症患者的肺炎发生率

Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients.

作者信息

Miron Ana-Aliana, Ifteni Petru Iulian, Lungu Alexandra-Elena, Dragomirescu Elena-Luiza, Dima Lorena, Teodorescu Andreea

机构信息

Facultatea de Medicină, Universitatea Transilvania din Brașov, Bulevardul Eroilor 29, 500036 Brașov, Romania.

Spitalul Clinic de Psihiatrie și Neurologie Brașov, Str. Prundului No. 7-9, 500123 Brașov, Romania.

出版信息

Medicina (Kaunas). 2025 Jul 10;61(7):1251. doi: 10.3390/medicina61071251.

Abstract

: Schizophrenia is a disabling psychiatric condition, affecting around 1% of people worldwide. It has been ranked among the ten most disabling conditions globally. Alongside the psychological and social burdens imposed on individuals suffering from this disease, there are also serious complications regarding the physical health of these patients. Pneumonia is a significant cause of death in patients with schizophrenia. This group of patients also has a higher risk of developing pneumonia and all-cause mortality compared to those without schizophrenia, along with an increased overall mortality rate. A retrospective study revealed that advanced age, underweight, smoking, and the use of high-dose atypical antipsychotics increase the risk of pneumonia-related mortality in hospitalized patients. Our study aims to examine differences in factors associated with pneumonia in hospitalized patients with schizophrenia, before and after the COVID-19 pandemic, as well as to identify potential changes in clinical characteristics and outcomes. : This is an observational, retrospective analysis, based on the review of medical records of psychiatric inpatients diagnosed with schizophrenia according to the DSM-5 criteria. Patients were selected according to the following criteria: both schizophrenia and pneumonia diagnoses, hospitalized in Spitalul Clinic de Psihiatrie si Neurologie Brasov during 1 March 2018-1 March 2020, and 1 March 2022-1 March 2024, respectively. : A total of 27 patients met the inclusion criteria; 13 patients (48%) were in the pre-pandemic group and 14 patients (52%) in the post-pandemic group. Contrary to other reports, our results showed relatively low pneumonia rates in hospitalized schizophrenia patients (1.02% pre-pandemic and 1.63% post-pandemic), and rates were higher in female patients (61.54% pre-pandemic and 71.43% post-pandemic). Post-pandemic, most cases (42.86%) were registered during summer, in a schizophrenia population with mostly urban residence and with lower smoking rates than the pre-pandemic group. Physical restraints were, however, more frequently utilized in the post-pandemic group. : Pneumonia risk factors might register a change in the post-pandemic years. Polypharmacy and physical restraints are probably underestimated risk factors for pneumonia in schizophrenia patients, while a multidisciplinary approach and preventive measures might exert a protective role.

摘要

精神分裂症是一种致残性精神疾病,全球约1%的人口受其影响。它在全球十大致残性疾病中名列前茅。除了给患有这种疾病的个体带来心理和社会负担外,这些患者的身体健康也存在严重并发症。肺炎是精神分裂症患者死亡的一个重要原因。与没有精神分裂症的患者相比,这组患者患肺炎和全因死亡率的风险更高,总体死亡率也有所上升。一项回顾性研究表明,高龄、体重过轻、吸烟以及使用高剂量非典型抗精神病药物会增加住院患者肺炎相关死亡率的风险。我们的研究旨在探讨新冠疫情前后住院精神分裂症患者中与肺炎相关的因素差异,并确定临床特征和结局的潜在变化。

这是一项观察性回顾性分析,基于对根据《精神疾病诊断与统计手册》第5版标准诊断为精神分裂症的精神病住院患者病历的审查。患者根据以下标准进行选择:同时患有精神分裂症和肺炎诊断,分别于2018年3月1日至2020年3月1日以及2022年3月1日至2024年3月1日在布拉索夫精神病与神经病学临床医院住院。

共有27名患者符合纳入标准;13名患者(48%)在疫情前组,14名患者(52%)在疫情后组。与其他报告相反,我们的结果显示住院精神分裂症患者的肺炎发生率相对较低(疫情前为1.02%,疫情后为1.63%),女性患者的发生率更高(疫情前为61.54%,疫情后为71.43%)。疫情后,大多数病例(42.86%)在夏季登记,精神分裂症患者大多居住在城市,吸烟率低于疫情前组。然而,疫情后组更频繁地使用身体约束措施。

疫情后几年肺炎的风险因素可能会发生变化。联合用药和身体约束措施可能是精神分裂症患者肺炎被低估的风险因素,而多学科方法和预防措施可能发挥保护作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验